The Florida Sun – Orlando Surgeon Who Removes Keloids Is The First In Nation To Use The Latest Technology
Dr. Kenrick Spence, a Central Florida doctor, discusses the benefits of the SRT-100+ for keloid removal at Hilcrest Plastic Surgery in Orlando. With over 18 million people suffering from keloids, the market to remove the painful and itchy overgrowths of scars is highly in demand in this community. Read the full article here.
MedicalResearch.com – Dermatologist (Dr. Kristine A. Romine, MD) Discusses Personalized Approach to Skin Cancer Treatment
Dr. Kristine A. Romine, MD, CEO and Founder of Camelback Dermatology & Skin Surgery in Phoenix, AZ, explains the difference the personalized approach to skin cancer treatment that SRT provides to skin cancer patients. Read the full article here.
Superficial Radio Therapy and our CEO, Joe Sardano, are making headlines with Dermatology Times. This article highlights the benefits of using SRT alongside Mohs surgery when treating skin cancer patients. With 80 percent of skin cancers appearing on the face and neck, a less invasive approach is very sought out by sufferers. Read the full […]
Over the past several years, Mr. Sardano, CEO of Sensus Healthcare, has worked tirelessly to offer a non-surgical solution for non-melanoma skin cancer and an effective treatment for keloid scars. The state-of-the-art Superficial Radio Therapy (SRT) technology is the non-surgical treatment option dermatologists and oncologists have been waiting for. Upon receiving the “Non-Physician Non-Surgical Innovator of […]
Inc. recently sat down with 19 successful founders and executives to discuss how they push themselves to the next level. When asked about his support system, CEO of Sensus Healthcare, Joe Sardano, said, “One maxim our team hangs onto is, ‘Who packs your parachute?’ This saying comes from an old story originated by a U.S. Navy […]
CEO, Chairman and Co-Founder of Sensus Healthcare, Joe Sardano, was recently interviewed for a feature in AAWC‘s research journal, Ostomy Wound Management (OWM). Read the full interview here.
BOCA RATON, Fla., July 31, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced that the Company’s CEO, Joe Sardano, has been named non-physician, nonsurgical “Innovator of the Year” at the 2018 Aesthetic Awards, hosted by The Aesthetic […]